Jun 8, 2022 | Featured, Research News, Technology Updates
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
Jun 6, 2022 | Featured, Research News, Technology Updates
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
May 30, 2022 | Featured, Research News, Technology Updates
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
May 23, 2022 | Featured, Research News, Technology Updates
Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...
May 16, 2022 | Featured, Research News, Technology Updates
Dexcom Chief Tech Officer Leach discusses G7’s European launch and FDA review, expanding Dexcom One as written by Ricky Zipp for MedTechDrive.com, 10 May 2022. Dexcom’s newest continuous glucose monitoring system, called G7, was released last quarter...
May 2, 2022 | Featured, Research News, Technology Updates
Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes was announced by Ypsomed.com, on 27 April 2022. Ypsomed, Abbott, and CamDiab will work to accelerate the development of an automated insulin delivery...